The world's scientific and social network for malaria professionals
Subscribe to free Newsletter | 10180 malaria professionals are enjoying the free benefits of MalariaWorld today

cerebral malaria

Plasmodium vivax cerebral malaria in an adult patient in Sudan

September 23, 2019 - 14:18 -- Open Access
Author(s): 
Maowia M. Mukhtar, Omer A. Eisawi, Seth A. Amanfo, Elwaleed M. Elamin, Zeinab S. Imam, Faiza M. Osman and Manasik E. Hamed
Reference: 
Malaria Journal 2019 18:316, 18 September 2019

Plasmodium vivax infection is rising in sub-Saharan Africa, where Plasmodium falciparum is responsible for more than 90% of malaria cases. While P. vivax is identified as a major cause of severe and cerebral malaria in South east Asia, the Pacific and South America, most of the severe and cerebral cases in Africa were attributed to P. falciparum. Cases of severe malaria due to P. vivax are emerging in Africa. A few severe P. vivax cases were reported in Eastern Sudan and they were underestimated due to the lack of accurate diagnosis, low parasitaemia and seldom use of rapid diagnostic tests (RDTs).

Person: 
Country: 
Medical Treatment: 

Blood brain barrier disruption in cerebral malaria: Beyond endothelial cell activation

July 16, 2019 - 16:18 -- Open Access
Author(s): 
Arnulfo Tunon-Ortiz, Tracey J. Lamb
Reference: 
PLoS Pathog 15(6): e1007786

Breakdown of the blood brain barrier (BBB) is a feature of cerebral malaria (CM), a manifestation of infection with Plasmodium falciparum parasites that currently has a 20% fatality rate and disproportionately affects children under 5 years old.

Not Open Access | γδ-T cells promote IFN-γ–dependent Plasmodium pathogenesis upon liver-stage infection

May 20, 2019 - 14:31 -- NOT Open Access
Author(s): 
Julie C. Ribot, Rita Neres, Ana Pamplona, et al.
Reference: 
PNAS May 14, 2019 116 (20) 9979-9988

Cerebral malaria (CM) is a major cause of death due to Plasmodium infection.

Not Open Access | MRI demonstrates glutamine antagonist-mediated reversal of cerebral malaria pathology in mice

December 20, 2018 - 03:27 -- NOT Open Access
Author(s): 
Brittany A. Riggle, Sanhita Sinharay, Dima A. Hammoud, et al.
Reference: 
PNAS December 18, 2018 115 (51) E12024-E12033

The deadliest complication of Plasmodium falciparum infection is cerebral malaria (CM), with a case fatality rate of 15 to 25% in African children despite effective antimalarial chemotherapy.

Medical Treatment: 

Brain swelling is independent of peripheral plasma cytokine levels in Malawian children with cerebral malaria

November 27, 2018 - 15:33 -- Open Access
Author(s): 
Visopo Harawa, Madi Njie, Stephen Rogerson, et al.
Reference: 
Malaria Journal 2018 17:435, 26 November 2018

Severe brain swelling in paediatric CM was independent of tested blood pro-inflammatory and anti-inflammatory cytokines which are markers of systemic inflammation.

Not Open Access | Glucose metabolism mediates disease tolerance in cerebral malaria

October 30, 2018 - 12:42 -- NOT Open Access
Author(s): 
Andrew Wang, Sarah C. Huen, Harding H. Luan, Kelly Baker, Henry Rinder, Carmen J. Booth, and Ruslan Medzhitov
Reference: 
PNAS October 23, 2018 115 (43) 11042-1104

Sickness behaviors are a conserved set of stereotypic responses to inflammatory diseases.

NOT Open Access | α-Tocopheryl succinate-suppressed development of cerebral malaria in mice

October 2, 2018 - 16:33 -- NOT Open Access
Author(s): 
Aiko Kume, Shunji Kasai, Hana Furuya & Hiroshi Suzuki
Reference: 
Parasitology Research, October 2018, Volume 117, Issue 10, pp 3177–3182

α-Tocopheryl succinate (α-TOS), a derivative of vitamin E, is synthesized by esterification of α-tocopherol.

Proteomic profiling of the plasma of Gambian children with cerebral malaria

September 25, 2018 - 15:15 -- Open Access
Author(s): 
Ehab M. Moussa, Honglei Huang, Climent Casals-Pascual, et al.
Reference: 
Malaria Journal 2018 17:337, 24 September 2018

The results indicate that increased tissue damage and hypercoagulability may play an important role in fatal CM.

Person: 

Not Open Access | Targeting the IL33–NLRP3 axis improves therapy for experimental cerebral malaria

July 14, 2018 - 15:27 -- NOT Open Access
Author(s): 
Patrick Strangward, Michael J. Haley, Kevin N. Couper, et al.
Reference: 
PNAS June 28, 2018. 201801737

Cerebral malaria (CM) is a serious neurological complication caused by Plasmodium falciparum infection.

Admission EEG findings in diverse paediatric cerebral malaria populations predict outcomes

May 22, 2018 - 14:14 -- Open Access
Author(s): 
Douglas G. Postels, Xiaoting Wu, Gretchen L. Birbeck, et al.
Reference: 
Malaria Journal 2018 17:208, 22 May 2018

Despite substantial demographic and clinical heterogeneity between subjects in Malawi and Uganda as well as different EEG readers at each site, EEG findings on admission predicted mortality and morbidity.

Pages

Subscribe to RSS - cerebral malaria